Carvounis C P, Carvounis G, Arbeit L A
J Clin Invest. 1981 Jun;67(6):1792-6. doi: 10.1172/jci110219.
This study investigates the endogenous kallikrein-kinin system's role as a modulator of vasopressin action in the toad urinary bladder. Kalli-krein inhibition by aprotinin, which results in decreased kinin production, significantly increased both vasopressin and 8-Br-cyclic (c) AMP-stimulated water flow. Kinin potentiation by the kininase II inhibitor captopril (SQ 14225) significantly decreased vasopressin and 8-Br-cAMP-stimulated water flow. In contrast to water flow, vasopressin-stimulated urea permeability was decreased by aprotinin and increased by captopril. We conclude that the endogenous kallikrein-kinin system represents a significant modulator of vasopressin action and it permits separate control of vasopressin-stimulated water flow and solute transport.
本研究调查了内源性激肽释放酶-激肽系统在蟾蜍膀胱中作为血管加压素作用调节剂的作用。抑肽酶抑制激肽释放酶,导致激肽生成减少,显著增加了血管加压素和8-溴环磷腺苷(8-Br-cAMP)刺激的水流量。激肽酶II抑制剂卡托普利(SQ 14225)增强激肽作用,显著降低血管加压素和8-Br-cAMP刺激的水流量。与水流量相反,抑肽酶降低了血管加压素刺激的尿素通透性,而卡托普利则增加了尿素通透性。我们得出结论,内源性激肽释放酶-激肽系统是血管加压素作用的重要调节剂,它允许对血管加压素刺激的水流量和溶质转运进行单独控制。